medigraphic.com
ISSN 1561-302X (Print)

2020, Number 4

<< Back Next >>

Rev cubana med 2020; 59 (4)

Neurological disorders associated with dengue virus infection

González-Losada C, Lozano GM

Language: Spanish
References: 18
Page: 1-7
PDF size: 240.19 Kb.


ABSTRACT

Introduction: Neurological disorders associated with dengue is an issue of vital importance in these times because the clinical spectrum of dengue has changed and atypical manifestations are being reported much frequently. Serotypes 2 and 3 are the most frequently related to neurological manifestations such as encephalitis, myelitis and Guillain-Barré syndrome.
Objective: To report a series of cases with neurological disorders associated with DENV infection and its clinical, humoral and imaging variables.
Clinical case report: All patients had, in the first instance, uncomplicated dengue clinical status due to 38.5º C fever and chills of sudden appearance, Cephalo-caudal maculo-papular rash that spares palms and soles, arthralgias, myalgias, frontal and retro-ocular headache, the latter due to the contraction of the superior rectus muscle of the eyeball. All confirmed with specific anti-dengue virus antibodies. One patient developed Guillain-Barré syndrome, another had encephalitis, bicytopenia, and compromised level of consciousness. The rest had transverse myelitis, meningoencephalitis and autoimmune encephalitis.
Conclusions: Neurological disorders associated with dengue virus should be suspected in every patient who is admitted with this infection and manifests any of the alterations described here.


REFERENCES

  1. Tamayo Escobar OE, García Olivera TM, Escobar Yéndez NV, González Rubio D, Castro Peraza O. La reemergencia del dengue: un gran desafío para el sistema sanitario latinoamericano y caribeño en pleno siglo XXI. Medisan. 2019[acceso: 07/02/2020];23(2):308-24. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192019000200308&ing=es

  2. Mustafa MS, Rasotgi V, Jain S, Gupta V. Discovery of fifth serotype of Dengue virus (DENV-5): A new public health dilemma in dengue control. Medical Journal, Armed Forces India. 2015;71(1)67-70. https://doi.org/10.1016/j.mjafi.2014.09.011

  3. Organización Mundial de la Salud. Dengue and severe dengue. 2019 Disponible en: http://www.who.int/mediacentre/factsheets/fs117/en/

  4. Dengue: Cuadro clínico. Centros para el Control y la Prevención de Enfermedades (Centers for Disease Control and Prevention). 2019. Disponible en: https://www.cdc.gov/dengue/prevention/index.html

  5. Garg RK, Malhotra HS, Jain A, Malhotra KP. Dengue-associated neuromuscular complications. Neurol India. 2015;63(4):497-516. https://doi.org/10.4103/0028-3886.161990

  6. Puccioni-Sohler M, Orsini M, Soares CN. Dengue: a new challenge for neurology. Neurol Int. 2012;4(3):65-70.

  7. Li GH, Ning ZJ, Liu YM, Li XH. Neurological Manifestations of Dengue Infection. Front. Cell. Infect. Microbiol. 2017;7:449. 1-13. https://org.org//10.3389/fcimb.2017.00449

  8. Puccioni-Sohler M, Rosadas C, Cabral-Castro MJ. Neurological complications in dengue infection: a review for clinical practice. Arq Neuropsiquiatr. 2013;71(9-B):667-71.

  9. Padilla Docal B, Iglesias González IM, Martínez Larrarte JP, González Losada C, Dorta Contreras AJ. Proceso neuroinflamatorio en pacientes con virus del dengue. Rev Neurol. 2017;64(4):188-90.

  10. Peres Tassara M, Oliveira Guilarde A, Moraes da Rocha BA, de Rezende Féres VC, Turchi Martelli CM. Neurological manifestations of dengue in Central Brazil. Rev Soc Bras Med Trop. 2017;50(3):379-82. Doi: https://doi.org//10.1590/0037-8682-0444-2016

  11. Romero ON, Perez GM, Andrade S, Gonzalez- VE, Borgaro PR, Villagomez-MS, et.al. Neurological complications and death in children with dengue virus infection: report of two cases. Journal of Venomous Animals and Toxins including Tropical Diseases. 2017;23:25. Doi: https://doi.org//10.1186/s40409-017-0115-x

  12. Organización Panamericana de la Salud/Organización Mundial de la Salud. Actualización Epidemiológica: Dengue. 11 nov 2019, Washington, D.C. OPS/OMS. 2019.

  13. Castellanos Arcís ML, López Fernández JM, Caballé Ferreiras M, García Alderete H. El consentimiento informado; una acción imprescindible en la investigación médica. Rev Cubana Estomatol. 2009[acceso: 29/05/2020];46(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75072009000100007&lng=es

  14. Salazar Raymond MB, Icaza Guevara MF, Alejo Machado OJ. La importancia de la ética en la investigación. Revista Universidad y Sociedad. 2018;10(1):305-11.

  15. Mena Lora AJ, Fernández J, Morales A, Soto Y, Feris-Iglesias J, Brito MO. Disease severity and mortality caused by dengue in a Dominican pediatric population. Am J Trop Med Hyg. 2014;90(1):169-72. https://doi.org/10.4269/ajtmh.13-0440

  16. Gan ES, Ting DHR, Chan KR. The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis, Expert Rev. Anti Infect. Ther. 2017;15:111-19.

  17. Reyes del Valle J, Salas Benito J, Soto Acosta R, del Ángel RM. Dengue Virus Cellular Receptors and Tropism. Curr Trop Med Rep. 2014;1:36-43. https://doi.org//10.1007/s40475-013-0002-7

  18. Nascimento Soares C, Cabral Castro M, Oliveira C, Claudio Faria L, Mauro Peralta J, Gomes de Freitas MR, et al. Oligosymptomatic dengue infection. A potential cause of Guillain-Barré síndrome. Arq Neuropsiquiatr. 2008;66(2A): 234-37.




2020     |     www.medigraphic.com